APAlireza Pasdar

Alireza Pasdar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alireza Pasdar has a total of 545 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genetic and epidemiological patterns of primary immunodeficiency diseases in Eastern Iranian patients

    by Mohammad Salehi, Hamid Ahanchian, Ehsan Ghayoor Karimiani, Mohammad Hassan Aelami, Nasrin Moazzen, Zeinab Neshati, Alireza Pasdar

    Primary immunodeficiency diseases (PIDs) are monogenic inborn immune disorders. Of currently listed 555 genetic inborn errors of immunity (IEI) in 10 IUIS categories, PIDs range from life-threatening severe combined immunodeficiency (SCID) to milder antibody deficiencies. PIDs increase mortality risk and demand genetic/immunological testing. In Iran, high consanguinity rates may warrant influence of genetic factors. Diagnostic challenges due to heterogeneity necessitate application of advanced tools like whole exome sequencing (WES). This study was carried out on Eastern Iran’s PIDs and similar approaches should be employed worldwide in populations that are highly consanguineous. This study focused on 99 patients from Eastern Iran clinically diagnosed with PIDs who were referred for genetic evaluations between 2016 and 2025. Genetic analyses involved DNA extraction from blood samples, WES using Illumina platforms, and in-house bioinformatic pipelines for variant identification and classification. Sanger sequencing and co-segregation studies further validated findings. Medical records, family histories, and pedigrees were thoroughly analyzed. Also we have delineated syndromic and non-syndromic PID disorders. The significant findings were as follows: Finding of 47 novel disease-causing variants; High consanguinity rates (76%) correlated with an 82.8% diagnostic yield and a mortality rate of 8% amongst patients. SCID-associated mutations, as the most common discovered PIDs, found in 16 cases; other common disorders were AR LRBA LOF, AR ATM LOF, and AR EPG5 (possibly hypomorphic LOF). Additionally, certain mutations may link to pregnancy loss which may need further functional studies. Around 70% of unresolved cases were syndromic. The most frequently suspected pathogenic variants (n = 5), all novel and in homozygosity with matching phenotype, were noted in EPG5 and linked to Vici syndrome. In highly consanguineous populations, WES may reach a definite or highly probable genetic diagnosis in over 80% of cases, and that some IEIs may be associated with pregnancy loss.

  • Association of Breast Cancer Risk with Genetic Polymorphisms rs889312 and rs4415084

    by Babak Rabbani, Soheila Jafarpour, Zahra Farshchian, Asma Khorshid-Shamshiri, Maryam Alidoust, Fatemeh Homaei-Shandiz, Alireza Pasdar, Fahimeh Afzaljavan

  • Open Access

    Network-based analysis of microRNAs targeting the RAS/MAPK signaling pathway in colorectal cancer

    by Sajjad Ataei Azimi, Elnaz Farzadifar, Alireza Pasdar, Forouzan Amerizadeh

    Introduction: Colorectal cancer remains one of the leading causes of cancer-related morbidity and mortality worldwide. The rat sarcoma/mitogen-activated protein kinase (RAS/MAPK) signaling pathway plays a pivotal role in the regulation of cellular proliferation, differentiation, and survival, and its dysregulation is strongly associated with colorectal tumorigenesis. Recent studies suggest that microRNAs (miRNAs) critically influence cancer progression by targeting key components of this pathway. Objectives: This study aimed to systematically investigate dysregulated miRNAs that target the RAS/MAPK signaling pathway in colorectal cancer and identify core regulatory genes, enriched biological functions, and potential therapeutic targets using a systems biology approach. Materials and Methods: In this in silico study, differentially expressed miRNAs in colorectal cancer were identified from comprehensive literature and validated via the miRDB database (score >90). High-confidence target genes were analyzed using STRING to construct protein-protein interaction (PPI) networks. Hub genes were detected using CytoHubba in Cytoscape through multiple centrality algorithms (MNC, MCC, DMNC, Degree). Gene ontology (GO), KEGG, and transcription factor enrichment were performed using Enrichr. Promoter motif analysis was conducted via Tomtom and GOMO, and DrugBank was used to evaluate druggability of hub proteins. Results: Several hub proteins, including STAT3, JUN, PTEN, ESR1, KRAS, and HIF1A, were identified as central components of the miRNA-target network. Gene ontology and KEGG enrichment highlighted their roles in transcriptional regulation, MAPK cascade, and cell proliferation. Promoter analysis revealed key regulatory motifs, while DrugBank analysis identified several approved and investigational compounds targeting these hub proteins. Conclusion: The integration of miRNA –gene interaction analysis with network biology and drug discovery tools provided novel insights into the regulatory mechanisms underlying colorectal cancer. Hub proteins identified in this study show potential for targeted therapy and biomarker development. This study highlights critical miRNAs regulating the RAS/MAPK pathway in colorectal cancer and provides a framework for therapeutic target prioritization through integrative network analysis.


  • Open Access

    Identification of novel biomarkers for epithelial ovarian cancer through machine learning and explainable artificial intelligence using in silico and in vitro analysis

    by Zahra Chekini, Toktam Dehghani, Reza Khayami, Amir Hossein Jafarian, Marjaneh Farazestanian, Malihe Hassanzadeh, Alireza Pasdar

    Epithelial ovarian cancer (EOC) is a lethal gynecological malignancy. Ongoing research aimed to identify novel biomarkers and develop combined algorithms to improve diagnosis and prognosis prediction for EOC. RNA-seq related to EOC were obtained from the Recount 3 databases data. We categorized early, late stages versus control, all stages (I-IV) versus control, and early versus late stages for machine learning, deep learning model and explainable AI (XAI). The hub genes were selected by considering SHapley Additive exPlanations (SHAP) analysis. The expression of hub genes was validated in fresh tissue (34 EOC, and 33 benign neoplastic ovarian) and peripheral blood mononuclear cell (PBMC) from 39 EOC, and 33 benign neoplastic ovarian patients using real time-PCR. For late stage and also all stages versus control, three hub genes were selected including SGO1, VTA1, RBM5-AS1 were mainly involved in cell cycle, estrogen signaling and vesicle trafficking. SGO1, and VTA1 were increased significantly in both tissue and PBMC of EOC patients (p < 0.05). RBM5-AS1 was significantly decreased in EOC tissue as well as PBMC compared to benign neoplastic ovarian patients (p < 0.05). VTA1 and RBM5-AS1 show promise as both diagnostic and prognostic markers, while SGO1 may serve primarily as a diagnostic biomarker for EOC.


  • Open Access

    Integrative Systems Biology Analysis of MicroRNA Regulation in Wnt Signaling Pathway During Breast Cancer Progression

    by Hossein Rahimi, Elnaz Farzadifar, Negar Mottaghi-Dastjerdi, Abozar Ghorbani, Forouzan Amerizadeh, Alireza Pasdar

    Background: Breast cancer poses a multifaceted challenge in oncology, demanding a comprehensive grasp of its molecular intricacies. Objectives: This in silico systems biology study explores the interplay between microRNA (miRNA) regulation and the Wnt/β-catenin pathway, both pivotal in breast cancer pathogenesis. MicroRNAs (miRNAs) exert influence over fundamental cancer hallmarks, functioning as either oncogenes or tumor suppressors. Methods: In this study, a list of miRNAs known to regulate the Wnt signaling pathway and reported to be dysregulated in breast cancer was retrieved from a recent comprehensive review article. These miRNAs formed the basis for downstream computational analyses. Using a collaborative systems biology framework, we analysed spans dysregulated miRNA expression targets, protein-protein interactions (PPIs), and identification of hub proteins. CytoCluster analysis was performed to identify dense regions in the protein subnetwork. In addition, the exploration of promoter motifs shows the importance of elements in hub proteins. Results: The study uncovers a nuanced miRNA-regulated network in breast cancer, emphasizing 15 pivotal hub proteins among 1 373 targeted proteins. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and gene ontology (GO) enrichment analysis revealed critical pathways and biological processes (BPs) regulated by proteins targeted by these miRNAs. Apart from the regulatory elements of intranuclear transcription, cytoskeleton proteins are also a major part of the targeted proteins in the formation and spread of breast cancer. CytoCluster analysis underscores the direct relevance of dysregulated miRNA-targeted genes to breast cancer. In contrast, promoter motif analysis sheds light on potential regulatory elements influencing hub protein expression, providing an improved comprehension of their roles in the advancement of cancer. Conclusions: This research advances our understanding of breast cancer at a molecular level, offering potential therapeutic targets and insights into signaling cascades, with future validations crucial for translating these findings into actionable interventions and refining breast cancer diagnostics, prognostics, and personalized treatment strategies. Given the in silico nature of this study, limitations related to data source selection and lack of experimental validation may introduce bias. The findings require further biological verification in future studies.


  • Open Access

    A Prospective to Regulatory Role of miRNAs on Wnt/β-catenin Signaling and Its Crosstalk to the Other Cellular Pathways in Tumorigenesis of Glioblastoma by a Systems Biology Approach

    by Morteza Saeidi, Alireza Pasdar, Farzad Rahmani, Abozar Ghorbani, Negar Mottaghi, Forouzan Amerizadeh

    Background: The Wnt plays a crucial role in the initiation, progression, and spread of glioblastoma (GBM). Recently, microRNAs (miRNAs) have been demonstrated to be key players in controlling cell growth and tumor formation. Objectives: The present study offers the latest insight into miRNAs that influence the Wnt pathway and their interaction with protein-coding genes. Methods: Previous studies on the regulatory function of miRNAs targeting the Wnt/catenin pathway were reviewed, and all miRNA-targeted genes were found in the miRDB database. Protein-protein interactions (PPIs) of miRNA-targeted genes were investigated using String and Cytoscape software, and hub proteins were examined. Gene-subnetwork Gene Ontology (GO) analysis was performed. Results: At first, 13 downregulated and 25 upregulated miRNAs targeting the Wnt pathway were obtained, each targeting 1,685 and 1,313 genes, respectively; 12 and 15 hub proteins were found in dysregulated miRNA-targeted genes, which interacted with most genes. The PPI network analysis and subnetwork GO analysis showed these proteins cross-talk with many other proteins that have key roles in the pathways that cause proliferation and malignancy in cells. Conclusions: Hub proteins are oncogenic proteins that increase gene replication and suppress apoptotic pathways, or tumor suppressors that prevent cancer. By focusing on hub proteins alone or as part of a multi-target approach, it is possible to treat GBM tumors successfully.


  • Investigation of differentially expressed genes and protein network analysis in synovium tissue of osteoarthritis patients

    by Masoumeh Salari, Alireza Pasdar, Forouzan Amerizadeh

    Introduction: Osteoarthritis is a degenerative joint disease that leads to chronic pain, inflammation, and cartilage degradation, primarily affecting the elderly. The molecular mechanisms underlying osteoarthritis remain poorly understood, necessitating a comprehensive study of gene expression and protein interactions to identify key pathways and therapeutic targets. Objectives: The primary objective of this study was to identify differentially expressed genes (DEGs) in synovial tissue of osteoarthritis patients and to analyze their associated protein-protein interaction (PPI) networks. By uncovering key regulatory genes, biological pathways, and potential drug targets, this research aims to enhance the understanding of osteoarthritis pathogenesis and contribute to the development of novel therapeutic strategies. Materials and Methods: In this cross-sectional study, DEGs were identified from synovial tissue samples of osteoarthritis patients and healthy controls. Gene ontology (GO) and pathway enrichment analysis were performed, followed by PPI network construction to identify hub genes. Thirteen hub genes were identified from synovial tissue samples of osteoarthritis patients through differential expression and PPI network analysis. Further analysis included drug-target prediction using DrugBank database, transcription factor analysis via ENCODE, and promoter motif exploration using Tomtom and GOMO databases. Results: Key pathways involved in osteoarthritis included PPAR signaling, lipolysis regulation, focal adhesion, and iron homeostasis. Drug-target analysis identified multiple candidates for pharmacological intervention, such as EGFR, TFRC, and LIPE. Promoter analysis revealed motifs linked to transcription factor activity, cytoskeletal organization, and inflammatory regulation, providing insight into upstream regulatory control. Conclusion: This study highlights key genes and pathways involved in osteoarthritis, particularly those related to lipid metabolism, inflammation, and transcriptional regulation. The identified hub genes and their druggable potential offer promising avenues for developing targeted therapies to manage or slow disease progression.

  • Open Access

    Host Genetic Variations and Their Implications on HBV and HCV Infection in the Iranian Population: A Comprehensive Systematic Review

    by Asma Khorshid Shamshiri, Forouzan Amerizadeh, Zahra Nasrpour Navaei, Alireza Pasdar

    Background: Background: Hepatitis virus infections are among the serious emerging health issues. They are the primary causes of cirrhosis and hepatocellular carcinoma. Growing evidence shows a link between certain genomic variations and inflammation including viral infection such as HBV and HCV. Therefore, this study aimed to comprehensively review studies that analyze the effect of host genomic variations on the risk of contracting viral hepatitis in Iranian population. Methods: The study was conducted according to the PRISMA Statement. All Persian and English case-control articles published until the beginning of June 2023 were included in the study. Two authors reviewed the articles independently. The third author reviewed the final results. Pathway analysis and protein interactions were also performed using GO and STRING databases. Results: Seventy relevant studies were retrieved. Fifty-three studies examined the association of SNPs with the risk of HBV infection. In terms of genetic variations, 25 genes and 44 SNPs were identified. Tumor necrosis factor alpha, Interleukin 28B, and Interleukin 10 were the most prevalent considered genes. The most common polymorphisms were in the interleukin family. Moreover, the top five identified molecular functions were cytokine activity, cytokine receptor binding, molecular function regulator, protein binding, and signaling receptor binding. Conclusion: The polymorphisms of genes involved in the production of immune factors, cytokines, interleukins, and their receptors are associated with the risk of HBV and HCV infections in the Iranian population. Moreover, the extracellular and intracellular signaling pathways and the regulating molecules of these processes can be considered as important factors in liability for these viral infections.

  • INHBB variants as genetic determinants of breast density modulate breast cancer risk

    by Vahideh Taherian, Asma Khorshid Shamshiri, Fatemeh Vakili, Fatemeh Homaei Shandiz, Donya Farrokh, Alireza Pasdar, Fahimeh Afzaljavan

  • Open Access

    Assessment of the Seroprevalence of Varicella zoster Virus in Young Adults Aged 15 – 35 Years Old in Mashhad, Iran

    by Mahdieh Khoshakhlagh, Samaneh Abolbashari, Alireza Pasdar, Mohammad Taghi Shakeri, Mojtaba Meshkat, Ahmad Ghasemifard, Amin Hooshyar Chechaklou, Soroush Yazdani, Ali Parvin, Navid Pousti, et al.

    Background: Varicella zoster virus (VZV) is highly contagious and can lead to two distinct diseases. Initially, it causes chickenpox, a primary infection common among children worldwide, characterized by itchy, red blisters that cover the body. After this initial outbreak, the virus can lie dormant in nerve tissues and may reactivate later in life as herpes zoster, commonly known as shingles, which presents as a painful rash. While chickenpox is generally mild and resolves on its own, it can cause severe complications, especially in vulnerable groups such as immunocompromised individuals or adults. These complications can range from bacterial superinfections and pneumonia to encephalitis. In rare cases, it may lead to life-threatening conditions like necrotizing fasciitis or toxic shock syndrome, highlighting the potential severity of what is often considered a childhood illness. Objectives: One of the main risk factors for varicella-zoster infection is the absence of immunity. Individuals who have not been vaccinated against or previously infected with the VZV are at risk of contracting chickenpox when exposed. Additionally, close contact with infected individuals increases the likelihood of transmission. People with chronic conditions or those undergoing immunosuppressive therapy are particularly vulnerable to severe complications from varicella-zoster infections. Therefore, this study was conducted to assess the seroepidemiology of antibodies against varicella zoster in the young adult population in Mashhad. Methods: This cross-sectional study was conducted in 2018 on men and women aged 15 to 35 years in Mashhad, northeast Iran. Random cluster sampling was utilized. Individuals undergoing treatment for rare diseases were excluded from the study. The enzyme-linked immunoassay (ELISA) technique was employed to assess the presence of IgG antibodies against varicella zoster in 724 serum samples. Data analysis was performed using SPSS 20, and the significance level was set at 0.05. Results: Overall, among the 724 participants aged 15 - 35 years old in Mashhad, the frequency of anti-varicella IgG seropositivity was 85.9%. Our results indicated significant associations between age (P = 0.001) and occupational status (P = 0.02) with varicella-zoster seroprevalence. Conclusions: We observed a high frequency of anti-varicella zoster IgG seroprevalence among young adults in Mashhad. Infants, pregnant women, and individuals with weakened immune systems are more likely to develop severe forms of chickenpox or experience complications from shingles, including pneumonia and encephalitis. Given the severe health problems caused by the varicella virus and its high prevalence in Mashhad, we recommend incorporating the varicella vaccine into the public vaccination program. Additionally, further examination of the burden of herpes zoster, including its impact on quality of life and healthcare utilization, can guide interventions to mitigate the consequences of this condition.